Page 60 - L:\GROUP\SDT\zip_disk\Book2.PDF
P. 60

initially negative PPD test result and who have not had a
                                              documented negative TB skin test result during the preceding 12
                                              months (See Appendix A, pg. 63).  TB skin tests shall be offered at a
                                              time and location convenient to workers.  Follow-up and treatment
                                              evaluations are also to be offered at no cost to the  workers.

                                              Note:  The reading and interpretation of the TB skin tests shall be
                                              performed by a qualified individual as described in the CDC
                                              Guidelines.


                                       b.     Periodic Evaluations.  TB skin testing shall be conducted every three
                                              (3) months for workers in high risk categories, every six (6) months
                                              for workers in intermediate risk categories, and annually for low
                                              risk personnel (The CDC has defined the criteria for high,
                                              intermediate, and low risk categories, see Appendix A, pg. 8-17).
                                              Workers with a documented positive TB skin test who have
                                              received treatment for disease or  preventive therapy for infection
                                              are exempt from the TB skin test but must be informed periodically
                                              about the symptoms of TB and the need for immediate  evaluation
                                              of any pulmonary symptoms suggestive of TB by a physician or
                                              trained health care provider to    determine if symptoms of TB
                                              disease have  developed.

                                              Note:  If the facility has not completed a risk assessment the CSHO
                                              shall review the TB related records to establish required testing
                                              frequencies for the facility and areas of the facility.


                                       c.     Reassessment following exposure or change in health.  Workers
                                              who experience exposure to an individual with suspect or
                                              confirmed infectious TB for whom infection control precautions
                                              have not been taken shall be managed according to CDC
                                              recommendations (Appendix A).  An employee who develops
                                              symptoms of TB disease shall be  immediately evaluated according
                                              to the CDC Guidelines.


                                3.     Case Management of Infected Employees shall include the following:

                                       a.     Protocol for New Converters.  Conversion to a positive TB skin test
                                              shall be followed as soon as possible, by  appropriate physical,
                                              laboratory, and radiographic evaluations to determine whether the
                                              employee has infectious TB disease. (see Appendix A, pg. 65).

                                       b.     Work Restrictions for Infectious Employees.  See Appendix A, page
                                              41.

                                4.     Worker Education and Training.     Training and information to ensure
                                       employee knowledge of such issues as the mode of TB transmission, its
                                       signs and symptoms, medical surveillance and therapy, and site specific
                                       protocols  including the purpose and proper use of controls shall be
                                       provided to all current employees and to new workers upon hiring.  (See


                                                            52
   55   56   57   58   59   60   61   62   63   64   65